FYLNETRA Trademark

Trademark Overview

On Friday, September 21, 2018, a trademark application was filed for FYLNETRA with the United States Patent and Trademark Office. The USPTO has given the FYLNETRA trademark a serial number of 88126983. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 16, 2022. This trademark is owned by Adello Biologics, LLC. The FYLNETRA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceuticals used for stimulating white blood cell production
fylnetra

General Information

Serial Number88126983
Word MarkFYLNETRA
Filing DateFriday, September 21, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 16, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 12, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, pharmaceuticals used for stimulating white blood cell production

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 28, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameKASHIV BIOSCIENCES, LLC
Party Type21 - New Owner After Publication
Legal Entity Type16 - Limited Liability Company
AddressPiscataway, NJ 08854
Party NameAdello Biologics, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressPiscataway, NJ 08854
Party NameAdello Biologics, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressPiscataway, NJ 08854

Trademark Events

Event DateEvent Description
Monday, May 16, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, May 16, 2022ABANDONMENT - NO USE STATEMENT FILED
Wednesday, October 20, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 19, 2021SOU EXTENSION 5 GRANTED
Monday, October 11, 2021SOU EXTENSION 5 FILED
Monday, October 18, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, October 11, 2021TEAS EXTENSION RECEIVED
Thursday, March 11, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 9, 2021SOU EXTENSION 4 GRANTED
Tuesday, March 9, 2021SOU EXTENSION 4 FILED
Tuesday, March 9, 2021TEAS EXTENSION RECEIVED
Tuesday, September 1, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 28, 2020SOU EXTENSION 3 GRANTED
Friday, August 28, 2020SOU EXTENSION 3 FILED
Friday, August 28, 2020TEAS EXTENSION RECEIVED
Friday, April 10, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 8, 2020SOU EXTENSION 2 GRANTED
Wednesday, April 8, 2020SOU EXTENSION 2 FILED
Wednesday, April 8, 2020TEAS EXTENSION RECEIVED
Wednesday, October 9, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 7, 2019SOU EXTENSION 1 GRANTED
Monday, October 7, 2019SOU EXTENSION 1 FILED
Monday, October 7, 2019TEAS EXTENSION RECEIVED
Tuesday, April 9, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, March 20, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, February 12, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 12, 2019PUBLISHED FOR OPPOSITION
Wednesday, January 23, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, January 3, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 3, 2019ASSIGNED TO EXAMINER
Friday, September 28, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, September 25, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

fylnetra white blood cell production stimulating used preparations namely pharmaceuticals pharmaceutical